| abstract |
The innovative combination of the various biological agents has enabled the development of various treating forms either for osteoporosis or for osteoarthritis or for the rapidity of fracture rehabilitation, in various forms. This treatment is favoured compared with the other treatments on the market since it does not require surgery and it is a rational treatment for definitive recovering and not for combating the disease and prolonging the duration of progression of the disease. These formulae are intended for the pharmaceutical industry. |